This article is more than 5 years old. Information may no longer be current.
Fox Chase Cancer Center staff receive recognition
Click Here to Manage Email Alerts
Three members of Fox Chase Cancer Center’s staff received special honors or awards this spring.
Mohan Doss, PhD, MCCPM, received the Outstanding Leadership Award in the field of dose–response on behalf of Scientists for Accurate Radiation Information during the International Dose–Response Society’s international conference.
Doss, associate professor and medical physicist at Fox Chase, is a founding member of Scientists for Accurate Radiation Information (SARI).
“SARI has taken several initiatives to correct the misinformation about the health effects of low-dose radiation,” Doss said in a press release. “We in SARI are pleased to receive this recognition of our efforts. Part of our mission at SARI is to help prevent unnecessary, radiation phobia-related deaths, morbidity, and injuries associated with distrust of radio-medical diagnostics/therapies.”
Richard E. Greenberg, MD, FACS, chief of urologic oncology at Fox Chase, received the American Urologic Association’s Residents Committee Teaching Award. The award recognizes an outstanding urology educator or program director who has dedicated part of his or her career to teaching residents and who influences residents to pursue a career in academic medicine.
Greenberg specializes in the treatment of prostate, kidney, testicular, penile, urethral, ureteral and bladder cancers.
“After obtaining knowledge, the next best thing is to pass it on,” Greenberg said in a press release. “I am honored to receive this award. The residents I work with are some of the hardest working people I know and I look forward to strengthening the urology program at Fox Chase with them.”
Steven J. Cohen, MD, chief of gastrointestinal medical oncology at Fox Chase, has been elected to serve as vice chair of the NCI Pancreas Task Force of the Gastrointestinal Steering Committee.
Cohen will lead discussions of clinical trial ideas under development, as well as participate in other task force decision-making activities.
“I will be in a position to help set and support the current national clinical trial landscape in pancreatic cancer and help to develop concepts and ideas from colleagues around the country,” Cohen said in a press release.